相关实验视频
Updated: Jul 5, 2025
07:59
Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
20.2K
针对炎症性和自身免疫性皮肤疾病的非生物免疫抑制药物
Danai Dionysia Kanatoula1, Euna Bodner1, Kamran Ghoreschi1
1Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
概括
非生物免疫抑制药物,如阿扎西奥普林和甲铁酸,是自身免疫性皮肤疾病的关键. 本综述详细介绍了它们的机制,副作用管理以及在怀孕,母乳养和接种疫苗期间的使用情况.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非生物免疫抑制药物是自身免疫和炎症性皮肤疾病的支柱.
- 最初用于治疗癌症或感染,如阿扎西奥普林,甲铁和达普松等药物现在主要用于皮肤病学中的免疫调节作用.
- 尽管在临床上广泛使用,但精确的作用机制和安全概况需要持续的研究和医生教育.
研究的目的:
- 为皮肤病学中常用的非生物免疫抑制药物的作用机制提供全面的概述.
- 详细说明与这些关键药物相关的不良反应的管理策略.
- 讨论在弱势群体中使用毒品的具体考虑,包括怀孕和母乳养期间以及与疫苗接种一起使用药物.
主要方法:
- 文献审查和现有临床数据和研究结果的综合.
- 对药理学机制的分析和记录的不良事件概况.
- 在特定的临床场景中编制药物管理指南和专家建议.
主要成果:
- 详细解释阿扎西奥普林,达普森,甲甲和氧化如何发挥其免疫抑制作用.
- 对每个药物的常见和严重不良事件的识别和分类,并提供实际的管理指南.
- 在怀孕和母乳养期间安全使用这些药物的基于证据的建议,以及管理疫苗相互作用的策略.
结论:
- 彻底了解药物机制和副作用管理对于优化皮肤病免疫抑制疗法患者的结果至关重要.
- 积极主动的管理策略对于解决医生怀疑和确保安全有效的治疗至关重要.
- 在怀孕,母乳养和接种疫苗期间管理免疫抑制药物的具体方案是必要的,以最大限度地降低风险并保持治疗效益.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
120
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
120
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:29Drugs for Treatment of Ulcerative Colitis in IBD
142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
252
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
252